drugset / Trial / NCT07194941
Efficacy and Safety of Fecal Microbiota Transfer (FMT) for Recurrent Urinary Tract Infections in Women
Phase 2
Completed
40 enrolled
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
RandomizedParallel-groupOpen-labelTreatment
Summary
Urinary tract infections (UTIs) are highly prevalent worldwide, especially in women, with frequent recurrences and significant healthcare costs. The proposed Phase II clinical trial will define dosing and administration strategies for FMT in recurrent UTIs. If effective, this ecological approach could provide a novel therapeutic alternative to antibiotics for one of the most common infectious diseases worldwide
Timeline
- Start
- 2022-08-25
- Primary completion
- 2025-02-28
- Completion
- 2025-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fecal Microbiota Transfer | Other / unclassified | 150 g | Oral |
| Subject | Fecal Microbiota Transfer | Other / unclassified | 300 g | Oral |